Kane Biotech – Q2 2017 Financial Results

WINNIPEG, Manitoba, Aug. 16, 2017 (GLOBE NEWSWIRE) — Kane Biotech Inc. (TSX-V:KNE) (the “Corporation” or “Kane Biotech”) is pleased to announce its Q2 2017 Financial Results. Highlights: Total Revenues: For the six months ended June 30, 2017 were $890,906, an...